Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2012
09/27/2012WO2012127441A1 Treatment of proliferative disorders with a chemiluminescent agent
09/27/2012WO2012127302A1 Acid addition salts of (3,5-bis trifluoromethyl)-n-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2ylamino)-phenyl]-benzamide
09/27/2012WO2012127277A2 Bendamustine anionic-catioinic cyclopolysaccharide compositions
09/27/2012WO2012127032A1 Novel pyrimidine derivatives
09/27/2012WO2012126901A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012WO2012126359A1 A drug carrier for tumor-targeted therapy, its preparation method and its use
09/27/2012WO2012126118A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
09/27/2012WO2012104263A3 1,4 oxazines as bace1 and/or bace2 inhibitors
09/27/2012WO2012099973A3 Compositions and methods for treating cancer
09/27/2012WO2012078586A3 Pharmaceutical composition comprising nanog shrna, and method of usnig nanog shrna to treat cancer
09/27/2012WO2012068319A3 Method of treating hematological cancers
09/27/2012WO2012058269A3 Methods of treating cancer and other diseases
09/27/2012WO2011135520A8 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders
09/27/2012WO2011112867A8 The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
09/27/2012US20120245235 Classification of cancers
09/27/2012US20120245209 Heterocyclic sulfonamide derivatives
09/27/2012US20120245206 Multi-cyclic compounds and methods of use
09/27/2012US20120245202 Methods and products for treating inflammation
09/27/2012US20120245198 Compounds and compositions for treatment of cancer
09/27/2012US20120245194 Small molecule inhibitors of the alpha4-paxillin interaction
09/27/2012US20120245190 Autophagy inducing compound and the uses thereof
09/27/2012US20120245189 Crystalline cdc7 inhibitor salts
09/27/2012US20120245186 Combination cancer therapy with hsp90 inhibitory compounds
09/27/2012US20120245183 Macrocyclic lactone derivatives for the treatment of cancer
09/27/2012US20120245182 Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1--1-methyl-urea and salts thereof
09/27/2012US20120245180 Combination
09/27/2012US20120245178 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
09/27/2012US20120245177 Crystalline levofolinic acid and process for its preparation
09/27/2012US20120245175 Mk2 inhibitors
09/27/2012US20120245174 Compounds and methods for kinase modulation, and indications therefor
09/27/2012US20120245171 Benzpyrazole derivatives as inhibitors of pi3 kinases
09/27/2012US20120245170 Pyrazolopyridine derivatives as anticancer agent
09/27/2012US20120245169 Certain chemical entities, compositions and methods
09/27/2012US20120245164 Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
09/27/2012US20120245162 Oxadiazole inhibitors of leukotriene production
09/27/2012US20120245151 Bisfluoroalkyl-1,4-benzodiazepinone compounds
09/27/2012US20120245150 NOVEL (HETEROCYCLE/TETRAHYDROPYRIDINE)-(PIPERAZINYL)-1-ALCANONE AND (HETEROCYCLE/DIHYDROPYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245149 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALKANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALKANONE DERIVATIVES AND USE THEREOF AS p75 INHIBITORS
09/27/2012US20120245144 Benzoxazepin compounds selective for pi3k p110 delta and methods of use
09/27/2012US20120245143 3-0x0-2,3-dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition
09/27/2012US20120245142 3-oxo-2,3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors
09/27/2012US20120245141 Activators of human pyruvate kinase
09/27/2012US20120245140 N-containing heteroaryl derivatives as jak3 kinase inhibitors
09/27/2012US20120245139 Inhibitors of the hedgehog pathway
09/27/2012US20120245138 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
09/27/2012US20120245135 Gallium Complexes, Pharmaceutical Compositions And Methods Of Use
09/27/2012US20120245134 Androgen pharmaceutical composition and method for treating depression
09/27/2012US20120245127 Methods of Treating Cell Proliferative Disorders
09/27/2012US20120245117 Methods of treating squamous cell lung cancer with 4-iodo-3-nitrobenzamide in combination with gemcitabine and carboplatin
09/27/2012US20120245112 Synthesis and identification of novel rsk-specific inhibitors
09/27/2012US20120245110 Vascular leakage inhibitor
09/27/2012US20120245101 Synthetic apolipoprotein e mimicking polypeptides and methods of use
09/27/2012US20120245099 Apoptosis inducer
09/27/2012US20120245092 Polypeptides having modulatory effects on cells
09/27/2012US20120245091 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells
09/27/2012US20120245089 Use of the sparc microenvironment signature in the treatment of cancer
09/27/2012US20120245086 WNT10-Derived Peptide and Use Thereof
09/27/2012US20120244230 Polyvalent polynucleotide nanoparticle conjugates as delivery vehicles for a chemotherapeutic agent
09/27/2012US20120244225 Au-Ag Core-Shell Nanorod Particles and Method for Producing Same
09/27/2012US20120244214 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
09/27/2012US20120244210 Composition for suppressing expression of target gene
09/27/2012US20120244209 Tusc2 therapies
09/27/2012US20120244193 Passive solid tumor targeting anticancer prodrug and preparation method thereof
09/27/2012US20120244181 Creating bioengineered lymph nodes
09/27/2012US20120244180 Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
09/27/2012US20120244175 Tumor specific animal proteins
09/27/2012US20120244173 Compositions and Methods for Enhancing Antigen-Specific Immune Responses
09/27/2012US20120244172 Conjudates of Pyrrolo[1,4]Benzodiazepine Dimers As Anticancer Agents
09/27/2012US20120244171 Cytotoxic benzodiazepine derivatives
09/27/2012US20120244170 Treating cancer by modulating mex-3
09/27/2012US20120244167 Antibodies to m-csf
09/27/2012US20120244164 Biological materials related to c-met
09/27/2012US20120244163 Bispecific binding agents targeting igf-1r and erbb3 signalling and uses thereof
09/27/2012US20120244162 Cross-species-specific bispecific binders
09/27/2012US20120244161 DOSAGE REGIMEN FOR ADMINISTERING AN EpCAMxCD3 BISPECIFIC ANTIBODY
09/27/2012US20120244151 Treatment of Cancer Involving Mutated KRAS or BRAF Genes
09/27/2012US20120244149 Benzoxazepin pi3k inhibitor compounds and methods of use
09/27/2012US20120244147 Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents
09/27/2012US20120244142 Antibody capable of recognizing hla class i
09/27/2012US20120244141 Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
09/27/2012US20120244133 Methods of growing tumor infiltrating lymphocytes in gas-permeable containers
09/27/2012US20120244132 T-cell receptor
09/27/2012US20120244131 Method for modulating the efficiency of double-strand break-induced mutagenesis
09/27/2012US20120244123 Therapeutic agents
09/27/2012US20120244118 Conjugates and compositions for immunotherapy and anti-tumoral treatment
09/27/2012US20120244116 Method of treatment of philadelphia chromosome positive leukaemia
09/27/2012US20120244115 Treating non-hematopoietic cancer with interleukin 6
09/27/2012US20120244112 Mutant interleukin-2 polypeptides
09/27/2012US20120244110 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012US20120244076 csPCNA Isoform Antibodies And Uses Thereof
09/27/2012US20120244075 5 NM Nickel-NTA-Gold Nanoparticles
09/27/2012US20120244068 Microorganisms for imaging and/or treatment of tumors
09/27/2012CA2836007A1 Mouse anti-aggrus monoclonal antibodies
09/27/2012CA2830953A1 Method and compositions for cellular immunotherapy
09/27/2012CA2830908A1 Methods and compositions for improving antiangiogenic therapy with anti-integrins
09/27/2012CA2830902A1 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
09/27/2012CA2830882A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
09/27/2012CA2830780A1 Azole compounds as pim inhibitors
09/27/2012CA2830772A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
09/27/2012CA2830628A1 Composition for treatment and diagnosis of pancreatic cancer
1 ... 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 ... 2211